NO913524D0 - Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav. - Google Patents

Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.

Info

Publication number
NO913524D0
NO913524D0 NO913524A NO913524A NO913524D0 NO 913524 D0 NO913524 D0 NO 913524D0 NO 913524 A NO913524 A NO 913524A NO 913524 A NO913524 A NO 913524A NO 913524 D0 NO913524 D0 NO 913524D0
Authority
NO
Norway
Prior art keywords
franeisseria
meningitidis
membrane protein
outer membrane
sequence coding
Prior art date
Application number
NO913524A
Other languages
English (en)
Inventor
Ricardo Silva Rodriguez
Evelin Caballero Menendez
Manuel Selman Houssein Sosa
Anabel Alvarez Acosta
Gerardo Guillen Nieto
Edelgis Couzeau Rodriguez
Luis Saturnino Herrer Martinez
Silian Cruz Leon
Julio Raul Fernandez Maso
Alexis Musacchio Lasa
Lidia Ines Novoa Perez
Juan Morales Grillo
Vivian Morera Cordova
Sonia Gonzalez Blanco
Original Assignee
Ingenieira Genetica Y Biotecno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ingenieira Genetica Y Biotecno filed Critical Ingenieira Genetica Y Biotecno
Publication of NO913524D0 publication Critical patent/NO913524D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01004—Dihydrolipoyl dehydrogenase (1.8.1.4), i.e. lipoamide-dehydrogenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO913524A 1990-09-07 1991-09-06 Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav. NO913524D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU90145A CU22302A1 (es) 1990-09-07 1990-09-07 Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales

Publications (1)

Publication Number Publication Date
NO913524D0 true NO913524D0 (no) 1991-09-06

Family

ID=5459451

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913524A NO913524D0 (no) 1990-09-07 1991-09-06 Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.

Country Status (15)

Country Link
US (1) US5286484A (no)
EP (1) EP0474313B1 (no)
JP (1) JP3253327B2 (no)
AR (1) AR245778A1 (no)
AT (1) ATE152175T1 (no)
AU (1) AU657487B2 (no)
CA (1) CA2050749C (no)
CU (1) CU22302A1 (no)
DE (1) DE69125769T2 (no)
ES (1) ES2103295T3 (no)
FI (1) FI103511B1 (no)
GR (1) GR3024127T3 (no)
IL (1) IL99401A (no)
NO (1) NO913524D0 (no)
RU (1) RU2132383C1 (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
WO1996000233A1 (en) * 1994-06-24 1996-01-04 Children's Hospital And Medical Center Escherichia coli o157:h7 epithelial adhesin
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
EP0970966B1 (en) * 1996-09-04 2008-02-20 Takara Bio Inc. Fungal antigens and process for producing the same
EP2278011A3 (en) * 1998-01-14 2012-03-07 Novartis Vaccines and Diagnostics S.r.l. Neisseria meningitidis antigens
AU3968599A (en) * 1998-04-29 1999-11-16 American Cyanamid Company Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis
AU761780B2 (en) * 1998-05-01 2003-06-12 Glaxosmithkline Biologicals Sa Neisseria meningitidis antigens and compositions
US6693186B2 (en) * 1998-09-01 2004-02-17 Antex Biologics Inc Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
US6756493B1 (en) * 1998-09-01 2004-06-29 Antex Biologics, Inc. Nucleic acid sequence and uses thereof
MXPA01003557A (es) * 1998-10-09 2004-04-05 Chiron Corp Secuencias genomicas de neisseria y metodos para su uso.
EP1535928B1 (en) * 1998-10-22 2008-07-16 The University of Montana Vaccine compositions comprising Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis
US6610306B2 (en) 1998-10-22 2003-08-26 The University Of Montana OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
CA2347849C (en) * 1998-10-22 2013-06-25 The University Of Montana Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
DE69839740D1 (de) 1998-10-22 2008-08-28 Univ Montana Vakzine enthaltend Omp85 Proteine von Neisseria gonorrhoeae und Neisseria meningitidis
JP4763210B2 (ja) 2000-02-28 2011-08-31 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ナイセリアのタンパク質の異種発現
WO2001081422A1 (en) * 2000-04-20 2001-11-01 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Secretory tyrosine phosphatases from mycobacteria
CU23077A1 (es) * 2000-12-06 2005-08-17 Centro Inmunologia Molecular Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas
CU23245A1 (es) * 2001-07-16 2007-10-17 Inst De Medicina Tropical Pedr CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
MXPA04012496A (es) 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Glicoformos del factor vii pegilados.
EP2255826B1 (en) * 2002-08-02 2016-04-13 GlaxoSmithKline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens
PT2353608T (pt) * 2002-10-11 2020-03-11 Novartis Vaccines And Diagnostics S R L Vacinas de polipéptidos para protecção alargada contra linhagens meningocócicas hipervirulentas
CN1738642A (zh) * 2002-11-14 2006-02-22 血清疫苗研究生产中心芬雷学院 获得缀合疫苗的方法和含有该缀合疫苗的疫苗组合物
CA2519092C (en) 2003-03-14 2014-08-05 Neose Technologies, Inc. Branched water-soluble polymers and their conjugates
WO2004091499A2 (en) 2003-04-09 2004-10-28 Neose Technologies, Inc. Intracellular formation of peptide conjugates
EP1615945B1 (en) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylation methods and proteins/peptides produced by the methods
ATE540055T1 (de) 2003-05-09 2012-01-15 Biogenerix Ag Zusammensetzungen und verfahren zur herstellung von glykosylierungsmutanten des menschlichen wachstumshormons
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
CN101072789B (zh) 2004-01-08 2013-05-15 生物种属学股份公司 肽的o-连接的糖基化
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
HUE026826T2 (en) 2004-10-29 2016-07-28 Ratiopharm Gmbh Modeling and glycopegylation of fibroblast growth factor (FGF)
CU23297A1 (es) * 2004-11-16 2008-07-24 Ct De Inmunologa A Molecular Formulaciones inmunoterapã0/00uticas para la inducciã"n de autoanticuerpos bloqueadores de la uniã"n de interleucina-2 a su receptor. su uso en el tratamiento del cã ncer
ES2449195T3 (es) 2005-01-10 2014-03-18 Ratiopharm Gmbh Factor estimulante de colonias de granulocitos glicopegilado
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP1888098A2 (en) 2005-05-25 2008-02-20 Neose Technologies, Inc. Glycopegylated erythropoietin formulations
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
CU23578A1 (es) 2005-09-16 2010-09-30 Ct Ingenieria Genetica Biotech Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
ES2516694T3 (es) 2006-07-21 2014-10-31 Ratiopharm Gmbh Glicosilación de péptidos a través de secuencias de glicosilación con unión en O
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
CU23630A1 (es) 2006-10-30 2011-02-24 Ct Ingenieria Genetica Biotech Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae
PL2144923T3 (pl) 2007-04-03 2013-12-31 Biogenerix Ag Sposoby leczenia z użyciem glikopegilowanego G-CSF
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
WO2009108806A1 (en) 2008-02-27 2009-09-03 Novo Nordisk A/S Conjugated factor viii molecules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン

Also Published As

Publication number Publication date
IL99401A0 (en) 1992-08-18
JP3253327B2 (ja) 2002-02-04
EP0474313B1 (en) 1997-04-23
ES2103295T3 (es) 1997-09-16
GR3024127T3 (en) 1997-10-31
CA2050749A1 (en) 1992-03-08
AU8368391A (en) 1992-03-12
EP0474313A3 (en) 1993-02-24
DE69125769T2 (de) 1997-11-27
EP0474313A2 (en) 1992-03-11
ATE152175T1 (de) 1997-05-15
IL99401A (en) 2003-12-10
RU2132383C1 (ru) 1999-06-27
FI103511B (fi) 1999-07-15
FI914129A (fi) 1992-03-08
CU22302A1 (es) 1995-01-31
DE69125769D1 (de) 1997-05-28
CA2050749C (en) 2002-07-02
FI103511B1 (fi) 1999-07-15
US5286484A (en) 1994-02-15
FI914129A0 (fi) 1991-09-03
JPH06169779A (ja) 1994-06-21
AR245778A1 (es) 1994-02-28
AU657487B2 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
NO913524D0 (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.
FI913215A0 (fi) Additionspolymeriseringskatalysator, som aktiveras medelst oxidering.
FI896138A0 (fi) Polyolpolyestrar som fuktighetsbarriaer foer livsmedel.
ITTO930280A0 (it) Menbrana per ultrafiltrazione, diafiltrazione e relativi procedimenti di impiego, verifica e fabbricazione.
FI893557A0 (fi) Polyestrar, som innehaoller en eterbrygga.
FI903028A0 (fi) Polymerbaserade blandningskompositioner, som innehaoller destrukturerad staerkelse.
NO166420C (no) Ventil.
FI894600A0 (fi) Ny sammansaettning som innehaoller isocyanat-reaktiva vaete innehaollande foereningar.
DE68905101D1 (de) Ventil.
FI894650A (fi) Antigen, som associerar till en human tumoer.
FI881910A (fi) Underlag i synnerhet foer personer som saknar roerelsefoermaoga.
FI905020A0 (fi) Orala kompositioner, som innehaoller monoperoxisyror.
FI920080A0 (fi) Kulfaongare, som uppstannar kulor.
FI895431A0 (fi) Material, foerdelaktigt i bandform foer anvaendning som omslagsmaterial.
FI890033A (fi) Bildskaermanordning som innehaoller en vaogformsgenerator.
FI890147A0 (fi) Aemnen som motverkar rytmstoerningar.
FI914981A0 (fi) Triazolopyridazinderivat, foerfarande foer deras framstaellning samt anvaendning som herbicider.
FI911218A (fi) Monteringsplatta, saerskilt foer hus som anvaends i fjaerrkommunikations- och databehandlingsteknik.
DK0522059T3 (da) Fastholdelsesindretning og forbindelsesindretning, som indbefatter fastholdelsesindretningen
NO920500D0 (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav
NO901758L (no) Reninhemmende dipeptider, fremgangsmaate for deres fremstilling, midler som inneholder disse og deres anvendelse.
IT1268116B1 (it) Sedia.
FI884358A (fi) Handverktyg som utfoer fram- och tillbakagaoende roerelse, speciellt en metallsaog.
NO904352D0 (no) Membran-skille anordning, samt fremgangsmaate for fremstilling.
FI912694A0 (fi) Mede foer barnvagn d.v.s. hjaelpanordning som underlaettar hanteringen.